Interim / Quarterly Report • Aug 25, 2023
Interim / Quarterly Report
Open in ViewerOpens in native device viewer

Belysse Group NV
Period ended June 30, 2023
Franklin Rooseveltlaan 172-174 8790 Waregem, België Registratienummer: 0671.974.626

| 1 | DECLARATION REGARDING THE INFORMATION PROVIDED IN THIS REPORT3 | |
|---|---|---|
| 2 | KEY FIGURES 4 | |
| 3 | MANAGEMENT DISCUSSION AND ANALYSIS OF THE RESULTS5 | |
| 3.1 | GROUP HIGHLIGHTS 5 | |
| 3.2 | BUSINESS UPDATE Q2 20235 | |
| 4 | OPERATING REVIEW PER SEGMENT 6 | |
| 4.1 | REVENUE AND ADJUSTED EBITDA PER DIVISION6 | |
| 4.1.1 | Q2 20236 | |
| 4.1.2 | H1 2023 6 | |
| 5 | OTHER FINANCIAL ITEMS REVIEW7 | |
| 5.1 | INTEGRATION AND RESTRUCTURING EXPENSES7 | |
| 5.2 | CHANGES IN INVENTORIES 7 | |
| 5.3 | EMPLOYEE BENEFIT EXPENSE 7 | |
| 5.4 | OTHER EXPENSE 7 | |
| 5.5 | NET FINANCING EXPENSES 7 | |
| 5.6 | TAXATION 7 | |
| 5.7 | EARNINGS PER SHARE FOR CONTINUING OPERATIONS7 | |
| 5.8 | CASHFLOW AND NET DEBT8 | |
| 6 | RISK FACTORS 8 | |
| 7 | CONSOLIDATED INTERIM FINANCIAL STATEMENTS9 | |
| 7.1 | CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME 9 | |
| 7.2 | CONSOLIDATED STATEMENT OF FINANCIAL POSITION10 | |
| 7.3 | CONSOLIDATED STATEMENT OF CASH FLOWS 11 | |
| 7.4 | CONSOLIDATED STATEMENT OF CHANGES IN EQUITY12 | |
| 7.5 | SELECTED EXPLANATORY NOTES TO THE CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS 13 | |
| 7.5.1 | SIGNIFICANT ACCOUNTING POLICIES13 | |
| 7.5.2 | SEGMENT REPORTING13 | |
| 7.5.3 | INTEGRATION AND RESTRUCTURING EXPENSES14 | |
| 7.5.4 | GOODWILL 14 | |
| 7.5.5 | NET DEBT RECONCILIATION14 | |
| 7.5.6 | RELATED PARTY TRANSACTIONS 15 | |
| 7.5.7 | COMMITMENTS15 | |
| 7.5.8 | EVENTS AFTER THE STATEMENT OF FINANCIAL POSITION DATE15 | |
| 8 | GLOSSARY: ALTERNATIVE PERFORMANCE MEASURES 16 | |
We, the undersigned declare that, to the best of our knowledge, the condensed financial statements for the sixmonths period ended June 30, 2023, which have been prepared in accordance with IAS 34 Interim Financial Reporting, as adopted by the European Union, give a true and fair view of the assets, liabilities, financial position and profit or loss of the Group and the undertakings included in the consolidation taken as a whole, and that the half-year report includes a fair review of the important events that have occurred during the first six months of the financial year and their impact on the condensed financial statements, together with a description of the principal risks and uncertainties for the remaining six months of the financial year.
Andy Rogiest Chief Financial Officer
Cyrille Ragoucy Chairman of the Board and Chief Executive Officer
| (€ thousands) | H1 2023 | H1 2022 |
|---|---|---|
| Results | ||
| Revenue | 155,605 | 164,181 |
| Adjusted EBITDA | 12,250 | 16,946 |
| Adjusted EBITDA Margin | 7.9% | 10.3% |
| Integration and restructuring expenses | (1,981) | (1,301) |
| EBITDA | 10,269 | 15,645 |
| Depreciation / amortisation | (9,740) | (8,471) |
| Operating profit / (loss) for the period | 529 | 7,174 |
| Net finance expenses | (8,351) | (11,603) |
| Income tax benefit / (expense) | (2,145) | (2,764) |
| Profit/(loss) for the period | (9,967) | (7,193) |
| Cash flow | ||
| Cash, cash equivalents and bank overdrafts at the | ||
| beginning of the period from continuing operations | 38,488 | 51,394 |
| Net cash generated / (used) by operating activities | 4,716 | 872 |
| Net cash used by investing activities | (5,670) | 158,624 |
| Net cash generated / (used) by financing activities | (10,592) | (175,054) |
| Financing and cash transactions between continued and | ||
| discontinued operations | - | 363 |
| Cash, cash equivalents and bank overdrafts at the end of | ||
| the period from continuing operations | 26,942 | 36,198 (1) |
(1) The cash of €36.2m as per H1 2022 contained a €4.6 m payable related to the final settlement of the Transaction and related fees and was paid in Q3 2022. Pro forma for this settlement payment, the comparable cash balance in H1 22 is 31,6M€.
In relation to Belysse' s financing agreements, the documentation provides for the effect of changes in accounting standards to be neutralized. As such, the application of IFRS 16 has no consequence for the Group's financing.
| (€ thousands) | H1 2023 | H1 2022 |
|---|---|---|
| Net debt1 | 127,408 | 118,381 |
| Leverage | 5.5 | 3.6 |
Note 1: IFRS 16 effect is excluded from the leverage comparison (see glossary)
Volumes in the US improved compared to Q1 2023 but were below last year due to a strong comparator with shipment of some large orders in Q2 2022. The EBITDA margin for Q2 2023 is back in line with historical performance after a temporary drop affected by higher raw material costs following the change of our main yarn supplier in 2022 which was finalized in Q1 2023.
In Europe, Q2 2023 results have been affected by lower volumes due to low footfall in the Residential segment and delay of Commercial projects. Unitary margins have improved compared to prior year due to sales price increases, despite peak raw material purchasing prices of last year affecting the Q2 2023 P&L due to First-in, First-out (FIFO) accounting.
Since the start of this year, we managed to open additional ways of raw materials sourcing globally lowering our purchasing prices. From a cash-flow standpoint, Belysse has already started to benefit from this new procurement strategy and the lower cost of energy vs 2022. If these lower costs had impacted the results immediately since the beginning of the year, our results of the European division for H1 2023 would have been higher by €4.5m. However, with FIFO accounting practice, these lower purchase prices will impact the results in H2 2023.
In response to the current weak demand across the European market, a fixed cost reduction program was implemented early July. We expect an in-year 2023 fixed cost reduction of €1.7m and an annualized permanent impact of €3.4m.
With the cost and cash flow improvements described above, assuming all else remains materially unchanged, Belysse is expecting a full year 2023 EBITDA above 2022 levels and a year-end leverage below 4.0x.
1 As defined in the SSN facility agreements, excluding IFRS16 impact but including sale and leasebacks
| (€ million, unless otherwise mentioned) | Q2 2023 |
Q2 2022 |
% Change | o/w organic |
o/w FX |
|---|---|---|---|---|---|
| Europe US |
35.4 43.6 |
42.4 46.8 |
(16.4)% (7.0)% |
||
| Cons olidat e d Re ve nue | 79.0 | 89.2 | (11.5)% | (10.7)% | (0.8)% |
| Europe | (1.6) | 1.3 | (223.1)% | ||
| US | 8.9 | 9.6 | (6.8)% | ||
| Cons olidat e d Adjus t e d EBITDA | 7.3 | 10.9 | (33.4)% | (32.2)% | (1.2)% |
| Europe | -4.7% | 3.2% | |||
| US | 20.5% | 20.5% | |||
| Cons olidat e d Adjus t e d EBITDA Margin | 9.2% | 12.2% |
| H1 | H1 | o/w | o/w | ||
|---|---|---|---|---|---|
| (€ million, unless otherwise mentioned) | 2023 | 2022 | % Change | organic | FX |
| Europe | 74.7 | 82.9 | (10.0)% | ||
| US | 81.0 | 81.3 | (0.4)% | ||
| Cons olidat e d Re ve nue | 155.6 | 164.2 | (5.2)% | (5.8)% | 0.6% |
| Europe | (1.6) | 1.3 | (221.9)% | ||
| US | 13.9 | 15.6 | (11.2)% | ||
| Cons olidat e d Adjus t e d EBITDA | 12.2 | 16.9 | (27.7)% | (28.2)% | 0.5% |
| Europe | -2.2% | 1.6% | |||
| US | 17.1% | 19.2% | |||
| Cons olidat e d Adjus t e d EBITDA Margin | 7.9% | 10.3% |
Integration and restructuring expenses over the first six months of 2023 are equal to €2.0m and mainly relate to severance payments in regards to the fixed cost reduction program that was executed early July.
Changes of inventories of Work-In-Progress and Finished Goods for the first six months of 2023 are equal to (€5.2m), as compared to €14.4m in the same period last year. The negative number for the period is driven by the reduction in inventory levels achieved during the first 6 months. In the US the reduction was driven by the successful completion of the yarn transition project, in Europe a make-to-order process was introduced for less frequently sold products.
Employee benefit expense for the first six months of 2023 are equal to €40.5m, as compared to €39.3m in the same period last year. This increase is mainly driven by the automatic wage indexation in Belgium and the increase in wages in the US driven by the inflationary environment.
Other expense for the first six months of 2023 are equal to €30.8m, as compared to €37.6m in the same period last year. This decrease is mainly driven by the lower energy and transportation cost as well as lower cost for temporary workforce.
Net finance expenses for the first six months of 2023 are equal to €8.4m, as compared to €11.6m in the same period last year. This decrease is mainly driven by the lower financing cost of the group since the debt repayments after the Disposal per 4th of April 2022.
There is an income tax expense of €2.1m for the six months ended 30 June 2023, as compared to an income tax expense of €2.8m in the same period last year. The H1 2023 net expense results from taxing the results of our US division and the fact that no DTA are recognized on the losses in Europe. The difference in tax expense year over year is mainly linked to the US division where H1 2023 results were somewhat lower compared to H1 2022 results. The normalized effective tax rate of the Group is around 25%.
The net earnings per share for the first six months of 2023 were a loss of €0.28, compared to a loss of €0.20 for the same period last year.
H1 Net Debt was €157.1m (including €29.7m of IFRS 16 lease liabilities), flat compared to last quarter (+0.5%). Leverage1 stands at 5.5x (4.6x Q1 2023), and total available liquidity (including headroom under the RCF) remains strong and has improved to €65m at the end of H1 (€64m end of Q1).
There are no material changes related to the risks and uncertainties for the Group as explained in the section "Summary of main risks" of the 2022 annual report.
1 As defined in the SSN facility agreements, excluding IFRS16 impact but including sale and leasebacks
| (€ thousands) | H1 2023 | H1 2022 |
|---|---|---|
| I. CONSOLIDATED INCOME STATEMENT | ||
| Revenue | 155,605 | 164,181 |
| Raw material expenses | (67,390) | (84,675) |
| Changes in inventories | (5,176) | 14,415 |
| Employee benefit expenses | (40,458) | (39,313) |
| Other income | 435 | (31) |
| Other expenses | (30,765) | (37,633) |
| Depreciation/ amortization | (9,740) | (8,471) |
| Adjusted Operating Profit (1) | 2,510 | 8,475 |
| Integration and restructuring expenses | (1,981) | (1,301) |
| Operating profit / (loss) (1) | 529 | 7,174 |
| Finance income | 39 | 7 |
| Finance expenses | (8,390) | (11,610) |
| Net finance expenses | (8,351) | (11,603) |
| Profit / (loss) before income taxes | (7,821) | (4,429) |
| Income tax benefit / (expense) | (2,145) | (2,764) |
| Profit / (loss) for the period from continuing operations | (9,967) | (7,193) |
| Profit/ (loss) for the period from discontinued operations | - | (55,083) |
| Profit/(loss) for the period | (9,967) | (62,276) |
| Attributable to: | ||
| Equity holders | (9,967) | (62,276) |
| Non-controlling interest | - | - |
| II. CONSOLIDATED OTHER COMPREHENSIVE INCOME | ||
| Items in other comprehensive income that may be subsequently | ||
| reclassified to P&L | ||
| Exchange differences on translating foreign operations | (2,289) | 13,984 |
| Changes in fair value of hedging instruments qualifying for | ||
| cash flow hedge accounting | - | 152 |
| Items in other comprehensive income that will not be reclassified | ||
| to P&L | ||
| Changes in deferred taxes | (40) | 242 |
| Changes in employee defined benefit obligations | (6) | (288) |
| Other comprehensive income for the period, net of tax for | ||
| continuing operations | (2,335) | 14,089 |
| Other comprehensive income for the period, net of tax for | ||
| discontinued operations | - | (1,762) |
| Total comprehensive income for the period | (12,302) | (49,949) |
| Basic and diluted earnings per share attributable to the | ||
| ordinary equity holders of the company | (0.28) | (1.73) |
| Basic and diluted earnings per share from continued | ||
| operations attributable to the ordinary equity holders of the | ||
| company | (0.28) | (0.20) |
| Basic and diluted earnings per share from discontinued | ||
| operations attributable to the ordinary equity holders of the | ||
| company | - | (1.53) |
Adjusted Operating Profit / Operating profit/(loss) are non-GAAP measures.
| (€ thousands) | 30 June 2023 | 31 Dec 2022 |
|---|---|---|
| Property, plant and equipment | 104,547 | 108,178 |
| Of which IFRS 16 related right-of-use assets (excluding sale-and | ||
| leaseback) | 26,278 | 29,388 |
| Land and buildings | 48,437 | 51,245 |
| Plant and machinery | 49,783 | 50,025 |
| Other fixtures and fittings, tools and equipment | 6,328 | 6,908 |
| Goodwill | 104,276 | 105,662 |
| Other intangible assets | 5,021 | 5, 432 |
| Deferred income tax assets | 436 | 829 |
| Trade and other receivables | 591 | 59 9 |
| Total non-current assets | 214,872 | 220,700 |
| Inventory | 64,423 | 76,177 |
| Trade and other receivables | 27,945 | 24,994 |
| Cash and cash equivalents | 26,942 | 38,488 |
| Total current assets | 119,310 | 1 39,660 |
| Total assets | 334,183 | 360,359 |
| Share capital | 252,950 | 2 52,950 |
| Share premium | 65,660 | 65,660 |
| Other comprehensive income | 3,531 | 5,866 |
| Retained earnings | (201,172) | (191,208) |
| Other reserves | (39,876) | (39,876) |
| Total equity | 81,093 | 93,392 |
| Senior Secured Notes | 132,270 | 130,745 |
| Bank and Other Borrowings | 38,188 | 41,590 |
| Of which IFRS 16 related lease liabilities (excluding sale-and-leaseback) | 22,817 | 25,577 |
| Deferred income tax liabilities | 6,508 | 6 ,355 |
| Provisions for other liabilities and charges | 2,145 | 2,176 |
| Employee benefit obligations | 150 | 150 |
| Total non-current liabilities | 179,260 | 181,015 |
| Senior Secured Notes | 1,627 | 1,611 |
| Bank and Other Borrowings | 8,842 | 8,760 |
| Of which IFRS 16 related lease liabilities (excluding sale-and-leaseback) | 6,875 | 6,872 |
| Other payroll and social related payables | 14,802 | 17,161 |
| Trade and other payables | 46,826 | 57,201 |
| Income tax liabilities | 1,732 | 1,219 |
| Total current liabilities | 73,829 | 85,952 |
| Total liabilities | 253,089 | 266,967 |
| Total equity and liabilities | 334,183 | 360,359 |
| (€ thousands) | H1 2023 | H1 2022 |
|---|---|---|
| I. CASH FLOW FROM OPERATING ACTIVITIES | ||
| Net profit / (loss) from the period | (9,967) | (7,193) |
| Adjustments for: | ||
| Income tax expense/(income) | 2,145 | 2,764 |
| Finance income | (39) | (7) |
| Financial expense | 8,390 | 11,610 |
| Depreciation, amortisation | 9,740 | 8,471 |
| (Gain)/loss on disposal of non-current assets | - | (2) |
| Movement in provisions and deferred revenue | (118) | 3,295 |
| Expense recognised in respect of equity-settled share | ||
| based payments | 3 | (66) |
| Fair value of derivatives | - | 125 |
| Cash generated before changes in working capital | 10,154 | 18,997 |
| Changes in working capital: | ||
| Inventories | 11,229 | (22,037) |
| Trade receivables | (2,714) | (6,249) |
| Trade payables | (8,362) | 20,565 |
| Other working capital | (4,503) | (7,830) |
| Cash generated after changes in working capital | 5,804 | 3,446 |
| Net income tax (paid) Net cash generated / (used) by operating activities |
(1,088) 4,716 |
(2,574) 872 |
| II. CASH FLOW FROM INVESTING ACTIVITIES | ||
| Acquisition of property, plant and equipment | (5,467) | (4,951) |
| Acquisition of intangibles | (203) | (42) |
| Proceeds from non-current assets | - | 163,618 |
| Net cash used by investing activities | (5,670) | 158,624 |
| IIII. CASH FLOW FROM FINANCING ACTIVITIES Interest and other finance charges paid, net |
(6,882) | (15,590) |
| Repayments of Senior Secured Notes | - | (102,818) |
| Repayments of borrowings with third parties | (3,710) | (56,646) |
| Net cash generated / (used) by financing activities | (10,592) | (175,054) |
| NET INCREASE/ (DECREASE ) IN CASH AND BANK | (11,546) | (15,558) |
| Cash, cash equivalents and bank overdrafts at the | ||
| beginning of the period from continuing operations Financing and cash transactions between continued and |
38,488 | 51,394 |
| discontinued operations | - | 363 |
| Cash, cash equivalents and bank overdrafts at the end of |
| (€ thousands) | Share capital |
Share premium |
Other comprehensive income |
Retained earnings |
Other reserves2 |
Total | Elements of comprehensive income from discontinued operations |
Total equity |
|---|---|---|---|---|---|---|---|---|
| Balance at 31 December 2021 | 252,950 | 65,660 | (4,836) | (15,140) | (39,876) | 258,759 | (162,767) | 95,991 |
| Profit / (loss) for the period | - | - | - | (13,287) | - | (13,287) | (54,459) | (67,746) |
| Other comprehensive income | ||||||||
| Exchange differences on translating foreign | - | - | 10,214 | - | - | 10,214 | 54,863 | 65,077 |
| operations Changes in fair value of hedging instruments |
||||||||
| qualifying for cash flow hedge accounting | - | - | 152 | - | - | 152 | - | 152 |
| Cumulative changes in deferred taxes | - | - | 268 | - | - | 268 | 158 | 425 |
| Cumulative changes in employee defined benefit | ||||||||
| obligations | - | - | 68 | - | - | 68 | (565) | (496) |
| Total other comprehensive income for the period | - | - | 10,702 | - | - | 10,702 | 54,456 | 65,158 |
| Total comprehensive income for the period | - | - | 10,702 | (13,287) | - | (2,585) | (3) | (2,587) |
| Change in scope1 | - | - | - | (162,770) | - | (162,770) | 162,770 | - |
| Equity-settled share-based payment plans | - | - | - | (12) | - | (12) | - | (12) |
| Balance at 31 December 2022 | 252,950 | 65,660 | 5,866 | (191,208) | (39,876) | 93,392 | - | 93,392 |
| Profit / (loss) for the period | - | - | - | (9,967) | - | (9,967) | - | (9,967) |
| Other comprehensive income | ||||||||
| Exchange differences on translating foreign | - | - | (2,289) | - | - | (2,289) | - | (2,289) |
| operations | ||||||||
| Cumulative changes in deferred taxes | - | - | (40) | - | - | (40) | - | (40) |
| Cumulative changes in employee defined benefit | - | - | (6) | - | - | (6) | - | (6) |
| obligations | ||||||||
| Total other comprehensive income for the period | - | - | (2,335) | - | - | (2,335) | - | (2,335) |
| Total comprehensive income for the period | - | - | (2,335) | (9,967) | - | (12,302) | - | (12,302) |
| Equity-settled share-based payment plans | - | - | - | 3 | - | 3 | - | 3 |
| Balance at 30 June 2023 | 252,950 | 65,660 | 3,531 | (201,172) | (39,876) | 81,093 | - | 81,093 |
1 Change in scope reflects the transfer of the elements of comprehensive income from discontinued operations to retained earnings of the group at completion date of the divestment without currency translation adjustments which are recycled over the income statement.
2 Other reserves were created as a result of certain pre IPO transactions. Refer to the 2017 annual report for more information
These consolidated condensed interim financial statements for the six months ended June 30, 2023 have been prepared in accordance with IAS 34 Interim financial reporting. They do not include all the notes of the type normally included in an annual report. Accordingly, this report is to be read in conjunction with the annual report for the year ended December 31, 2022 and any public announcements made by the Belysse Group during the interim reporting period.
The amounts in this document are presented in thousands of euro, unless otherwise stated. Rounding adjustments have been made in calculating some of the financial information included in these consolidated condensed interim financial statements.
The accounting policies are consistent with those of the previous financial year and corresponding interim period. There are no IFRS standards issued but not yet effective which are expected to have an material impact on Belysse's financials.
Segment information is presented in respect of the Company's business segments. The performances of the segments is reviewed by the chief operating decision maker, which is the Management Committee.
| Previous | ||
|---|---|---|
| reported | ||
| (€ thousands) | H1 2023 | figures (1) |
| Revenue by segment | 155,605 | 164,181 |
| Europe | 74,653 | 82,912 |
| US | 80,952 | 81,270 |
| Discontinued Operations | - | 96,729 |
| Revenue by geography | 155,605 | 164,181 |
| Europe | 63,604 | 69,705 |
| North America | 83,099 | 83,859 |
| Rest of World | 8,902 | 10,618 |
| Discontinued Operations | - | 96,729 |
| Adjusted EBITDA by segment | 12,250 | 16,946 |
| Europe | (1,619) | 1,329 |
| US | 13,869 | 15,617 |
| Discontinued Operations | - | 7,140 |
| Net Capital expenditure by segment | 5,670 | 5,076 |
| Europe | 3,575 | 2,747 |
| US | 2,095 | 2,329 |
| Discontinued Operations | - | 5,209 |
| Net inventory by segment | 64,423 | 76,177 |
| Europe | 37,678 | 47,333 |
| US | 26,745 | 28,844 |
| Trade receivables by segment | 25,564 | 24,994 |
| Europe | 7,078 | 7,915 |
| US | 18,486 | 17,079 |
1 For Revenue, Adjusted EBITDA and Capital Expenditure, the previous reporting period refers to June 30, 2022. The previous period for Net inventory and Trade Receivables refers to December 31, 2022.
The following table sets forth integration and restructuring expenses for the period ended June 30, 2023 and 2022. This comprises various items which are considered by management as non-recurring or unusual by nature.
| (€ thousands) | H1 2023 | H1 2022 |
|---|---|---|
| Integration and restructuring expenses | 1,981 | 1,301 |
| Corporate restructuring | 1,981 | 1,301 |
Integration and restructuring expenses over the first six months of 2023 mainly relate to severance payments in regards to the fixed cost reduction program that was executed early July.
The goodwill decreased by €1.4m from €105.7m as of December, 2022 to €104.3m as of June 30, 2023. The decrease in goodwill reflects the changes in foreign exchange rate from the US dollar to euro from the date of acquisition of Bentley. The related foreign exchange fluctuations are presented in other comprehensive income.
The following table reconciles the net cash flow to movements in net debt:
| Liabilities from financing activities | Cash and Cash equivalents |
|||||||
|---|---|---|---|---|---|---|---|---|
| Senior Secured Notes due after 1 year |
Senior Secured Notes due within 1 year |
Lease liabilities due after 1 year |
Lease liabilities due within 1 year |
Super Senior RCF |
Total gross financial debt |
Cash and Cash equivalents |
Total net financial debt |
|
| (€ thousands) | ||||||||
| Net debt as at 31 December 2022 |
(132,489) | (3,479) | (42,004) | (8,849) | (82) | (186,903) | 38,488 | (148,415) |
| Cashflows | - | - | - | - | - | - | (11,546) | (11,546) |
| Repayments of borrowings with third parties Non- cash movements |
- | - | - | 4,061 | - | 4,061 | - | 4,061 |
| (including FX) | (653) | 107 | 3,488 | (4,154) | 11 | (1,201) | - | (1,201) |
| Net debt as at 30 June | ||||||||
| 2023 | (133,142) | ( 3,371) | (38,517) | (8,942) | (71) | (184,043) | 26,942 | (157,101) |
The table above does not include the movements in capitalized financing fees, or the interest paid.
Net Debt was €157.1m (including €29.7m of IFRS 16 lease liabilities), flat compared to last quarter (+0.5%).
The related party transactions with shareholders and parties related to the shareholders have not substantially changed in nature and impact compared to the year ended December 31, 2022 and hence no updated information is included in this interim report.
The remuneration of key management is determined on an annual basis, for which reason no further details are included in this interim report.
There is no significant evolution to report in terms of commitments. Please refer to Note 35 'Commitments' in the IFRS Financial Statements of the 2022 annual report.
No subsequent events occurred which could have a significant impact on the interim condensed financial statements of the Group per June 30, 2023.
The following alternative performance measures (non-IFRS) have been used as management believes that they are widely used by certain investors, securities analysts and other interested parties as supplemental measures of performance and liquidity. The alternative performance measures may not be comparable to similarly titled measures of other companies, have limitations as analytical tools and should not be considered in isolation or as a substitute for analysis of our operating results, our performance or our liquidity under IFRS.
Organic Growth is defined as growth excluding (i) FX impact, which comprises the translation of key foreign entities and (ii) M&A impact.
Adjusted EBITDA is defined as operating profit / (loss) adjusted for (i) the impact of the purchase price allocation mainly on change in inventories, (ii) gains on asset disposals, (iii) integration and restructuring expenses, (iv) depreciation / amortization and (v) impairment and write-off.
Adjusted EBITDA margin is defined as the Adjusted EBITDA as a percentage of revenue.
Adjusted Operating Profit/Loss is defined as operating profit/(loss) adjusted for (i) the impact of the purchase price allocation mainly on changes in inventory, (ii) gains on assets disposals, (iii) integration and restructuring expenses and (iv) impairment and write-off.
Gross Debt is defined as (i) Senior Secured Notes adjusted for the financing fees included in the carrying amount and (ii) Bank and other borrowings adjusted for capitalized financing fees.
Net Debt is defined as (i) Senior Secured Notes adjusted for the financing fees included in the carrying amount, (ii) Bank and other borrowings adjusted for capitalized financing fees less (iii) cash and cash equivalents.
Net-investment or net-CAPEX is defined as of the sum of all investments in tangible and intangible fixed assets adjusted for proceeds from sales of fixed assets.
Leverage is defined as the ratio of Net Debt to Adjusted EBITDA (excluding IFRS16 impacts as per financing documentation, except for sale-and-leaseback transactions).
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.